Høj fysisk aktivitet ved kronisk obstruktiv lungesygdom er en vigtig del af behandlingen
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Høj fysisk aktivitet ved kronisk obstruktiv lungesygdom er en vigtig del af behandlingen. / Rugbjerg, Mette; Lange, Peter; Iepsen, Ulrik Winning.
I: Ugeskrift for Laeger, Bind 178, Nr. 8, V05150450, 18.04.2016, s. 765-768.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Høj fysisk aktivitet ved kronisk obstruktiv lungesygdom er en vigtig del af behandlingen
AU - Rugbjerg, Mette
AU - Lange, Peter
AU - Iepsen, Ulrik Winning
PY - 2016/4/18
Y1 - 2016/4/18
N2 - High physical activity is important in chronic obstructive pulmonary disease treatmentPatients with chronic obstructive pulmonary disease (COPD) have lower activity levels than healthy controls. Loss of skeletal muscle affects COPD negatively, and strengthening of the musculature is probably part of the explanation for the positive effects of physical activity. This review describes the recent literature on restoring and maintaining physical activity in COPD and the importance of maintaining high physical activity levels. Furthermore, the future perspectives for research in COPD, physical activity, and the possible mechanisms for the beneficial effects are discussed.
AB - High physical activity is important in chronic obstructive pulmonary disease treatmentPatients with chronic obstructive pulmonary disease (COPD) have lower activity levels than healthy controls. Loss of skeletal muscle affects COPD negatively, and strengthening of the musculature is probably part of the explanation for the positive effects of physical activity. This review describes the recent literature on restoring and maintaining physical activity in COPD and the importance of maintaining high physical activity levels. Furthermore, the future perspectives for research in COPD, physical activity, and the possible mechanisms for the beneficial effects are discussed.
M3 - Tidsskriftartikel
C2 - 26509455
VL - 178
SP - 765
EP - 768
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 8
M1 - V05150450
ER -
ID: 153787612